title: Comparative effectiveness: the employer perspective.
abstract: Biopharmaceuticals are rapidly emerging as a focal point of concern in benefit design. CE initiatives may prove their value, but controlling costs will be up to consumers.
authors.forename: Marc B
authors.initials: MB
authors.lastname: Royo